- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:starting:safety_warnings [09.15.2017] – [Notes and comments] sallieq | home:starting:safety_warnings [10.19.2018] – [Immunopathology is dangerous and may be difficult to control] sallieq | ||
|---|---|---|---|
| Line 31: | Line 31: | ||
| * why higher than normal doses of olmesartan (Benicar) are required | * why higher than normal doses of olmesartan (Benicar) are required | ||
| * why the use of antibiotics while taking olmesartan can provoke dangerous levels of immunopathology | * why the use of antibiotics while taking olmesartan can provoke dangerous levels of immunopathology | ||
| - | * why the use of azithromycin or telmisartan is considered particularly dangerous | + | * why the use of telmisartan |
| It has been the experience of the staff and volunteers of Autoimmunity Research Foundation that those patients who understand the rationale for the different components and instructions of the MP have the most success and best treatment outcomes. | It has been the experience of the staff and volunteers of Autoimmunity Research Foundation that those patients who understand the rationale for the different components and instructions of the MP have the most success and best treatment outcomes. | ||
| - | ===== Patients' | + | ===== Patients' |
| Some [[physician|physicians]] consent to treat a patient with the MP after a cursory examination of the various [[home: | Some [[physician|physicians]] consent to treat a patient with the MP after a cursory examination of the various [[home: | ||
| Line 66: | Line 66: | ||
| - | ===== Immunopathology | + | ===== Immunopathology |
| < | < | ||
home/starting/safety_warnings.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.